Related Experiment Video
Updated: Aug 16, 2025
09:22
In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein
Published on: January 2, 2015
18.5K
Heparan Sulfate Proteoglycans in Tauopathy
Yanan Zhu1, Lauren Gandy2, Fuming Zhang2
1Department of Molecular Pharmacology & Physiology, Byrd Alzheimer's Research Institute, Morsani College of Medicine, University of South Florida, Tampa, FL 33612, USA.
Biomolecules
|December 23, 2022
Summary
Heparan sulfate proteoglycans (HSPGs) are implicated in tauopathies like Alzheimer's disease. Targeting HSPG-tau interactions may offer new therapeutic strategies for these neurodegenerative conditions.
Area of Science:
- Neuroscience
- Biochemistry
- Pathology
Background:
- Tauopathies, including Alzheimer's disease, involve tau protein aggregation and cognitive decline.
- Heparan sulfate proteoglycans (HSPGs), key extracellular matrix components, are increasingly recognized for their role in tauopathies.
- HSPGs co-deposit with tau in Alzheimer's brains and influence tau pathology.
Purpose of the Study:
- To review the current understanding of HSPG functions in tauopathies.
- To summarize the molecular pathways modulated by HSPGs in the context of tau pathology.
- To explore the therapeutic potential of targeting HSPG-tau interactions.
Main Methods:
- Literature review of existing research on heparan sulfate proteoglycans and tauopathies.
- Analysis of studies investigating HSPG-tau binding and modulation of tau dynamics.
- Examination of evidence linking dysregulated HSPG expression to tau pathology.
Main Results:
- HSPGs directly bind to tau, affecting its secretion, internalization, and aggregation.
- Dysregulated HSPG expression is associated with the progression of tau pathology.
- HSPG-tau interactions represent a significant pathway in the pathogenesis of tauopathies.
Conclusions:
- Heparan sulfate proteoglycans play a critical role in the development and progression of tauopathies.
- Targeting the interaction between HSPGs and tau presents a promising novel therapeutic avenue.
- Further research into HSPG-tau pathways could lead to effective treatments for neurodegenerative diseases.
Related Concept Videos
01:05Proteoglycans
4.0K
Glycans, a class of complex heterogeneous molecules, can be covalently attached to proteins to form glycosylated proteins that regulate various physiological and pathological processes. Glycosylated proteins or glycoproteins comprise N-linked and O-linked oligosaccharides. O-glycosylation is the most common type of protein glycosylation. Here, glycans attach to the oxygen atom of the hydroxyl groups of Serine or Threonine residues. O-linked glycosylation occurs later in protein processing,...
4.0K
01:23Glycosaminoglycans
5.0K
Glycosaminoglycans (GAGs), also known as mucopolysaccharides, are long and linear polymers comprising of specific repeating disaccharides - the amino sugar that can be N-acetylglucosamine or N-acetylgalactosamine, and a uronic acid that is usually glucuronic acid or iduronic acid.
GAGS are found in the extracellular matrix of vertebrates, invertebrates, and bacteria. Due to their polar nature they attract water, and serve as excellent lubricants or shock absorbers in an animal body.
Hyaluronic...
GAGS are found in the extracellular matrix of vertebrates, invertebrates, and bacteria. Due to their polar nature they attract water, and serve as excellent lubricants or shock absorbers in an animal body.
Hyaluronic...
5.0K
01:13The Proteasome
970
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
970
03:03Amyloid Fibrils
9.7K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.7K
01:21Matrix Proteoglycans and Glycoproteins
4.0K
Proteoglycans are extensively glycosylated proteins, commonly found in the extracellular matrix, interwoven with collagen fibers. Hyaline cartilage, the most common type of cartilage in the body, consists of short and dispersed collagen fibers associated with large amounts of proteoglycans. These proteoglycans have long negative charges that attract cations, which in turn attract water molecules. This influx of ions and water molecules swells up the proteoglycan like a water-soaked gel that can...
4.0K
01:24Oligosaccharide Assembly
2.9K
Protein glycosylation starts in the ER lumen and continues in the Golgi apparatus. Glycosyltransferases catalyze the addition of sugar molecules or glycosylation of proteins. Usually, these enzymes add sugars to the hydroxyl groups of selected serine or threonine residues to form O-linked glycans or the amino groups of asparagine residues to form N-linked glycans. Different positions on the same polypeptide chain can contain differently linked glycans.
Multiple sugar molecules that may or may...
Multiple sugar molecules that may or may...
2.9K